SIU 2017 Prostate Cancer - Results from #40

Viewing 41-56 of 56 articles

SIU 2017: Prostate Cancer Can Be Detected Even in Patients with Decreased PSA after Antibiotic Therapy

SIU 2017: Automatic Grading of Prostate Cancer using the Gleason Grading Groups

SIU 2017: Presence of Only Clinical Stage T2c Is Not Sufficient to be Classified as High Risk Prostate Cancer

SIU 2017: GA-PSMA-PET/CT VS. Choline-PET/CT in Malignant Prostate Cancer - A Systematic Review

SIU 2017: Comparison of 68Ga-PSMA-PETCT with Multiparametric MRI for Staging High Risk Prostate Cancer

SIU 2017: Comparison of Multiparametric and Biparametric MRI Cognitive Targeted First Round Prostate Biopsy for Patients with a PSA Level under 10 Ng/Ml

SIU 2017: Impact of Canadian Task Force on Preventative Health Care Recommendation Against PSA Screening on Radical Prostatectomy Results

SIU 2017: Novel Classification of Gleason 7 Prostate Cancer According to the Discrepancy between Biopsy and Final Gleason Score after Radical Prostatectomy

SIU 2017: Local Treatment for Metastatic Prostate Cancer

SIU 2017: Radiogenomics, MRI & Prostate Cancer Imaging

SIU 2017: Therapy for Prostate Cancer - Who and How?

SIU 2017: Advanced Risk Modeling for Prostate Cancer

SIU 2017: DNA Repair Mutations and Prostate Cancer

SIU 2017: The USPSTF Screening Review - What Are the Implications?

SIU 2017: Active Surveillance: Biopsy vs MRI for Follow Up

SIU 2017: Prostate Cancer Stem Cells

1
2
3